首页 › 基金 › Integral Health Asset Management, LLC › FBRX

Integral Health Asset Management, LLC 对 FBRX 的持仓历史

FORTE BIOSCIENCES INC

Integral Health Asset Management, LLC 在 Q2 2026 的 13F 申报中披露持有 FBRX(FORTE BIOSCIENCES INC)675,000 股,市值约 US$14.3M,约占其申报组合的 0.65%,在其申报持仓中市值排名第 48 位。 Integral Health Asset Management, LLC 最近 2 个申报季度中有 2 个季度披露了 FBRX 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q2 2026)675.00K 股
申报持仓市值$14.34M
组合权重0.65%
首次申报Q1 2026
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Integral Health Asset Management, LLC 对 FBRX 的持仓演变

Integral Health Asset Management, LLC 于 Q1 2026 首次披露 FBRX 持仓:150,000 股(约 US$3.9M)。 该持仓在 Q2 2026 达到峰值 675,000 股,市值约 US$14.3M。 在 2 次申报中,Integral Health Asset Management, LLC 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 675,000 股、市值约 US$14.3M,环比增持 525,000 股。。 持仓曾出现大幅变动:Q2 2026 增持约 350%。

逐季持仓明细

季度股数金额变化
Q1 2026 150.00K $3.88M 新进
Q2 2026 675.00K $14.34M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 FBRX 与 13F 数据

FBRX(FORTE BIOSCIENCES INC)的行业分类暂缺。我们追踪的基金中还有 70 只申报持有 FBRX,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$33.5M), Affinity Asset Advisors, LLC (US$24.3M), MPM BioImpact LLC (US$21.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 FBRX 的基金

查看 FBRX 的全部基金持有人 →

常见问题

How long has Integral Health Asset Management, LLC held FBRX?

Integral Health Asset Management, LLC has disclosed FBRX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Integral Health Asset Management, LLC's current position in FBRX?

As of Q2 2026, Integral Health Asset Management, LLC holds 675.00K shares of FBRX (FORTE BIOSCIENCES INC), valued at $14.34M, representing 0.65% of its reported portfolio and ranking #48.

Has Integral Health Asset Management, LLC been buying or selling FBRX?

In the latest 13F filing (Q2 2026), Integral Health Asset Management, LLC increased its position in FBRX. The position peaked in Q2 2026 at 675.00K shares.

Which other funds hold FBRX?

Other major institutional holders of FBRX include ORBIMED ADVISORS LLC, Affinity Asset Advisors, LLC, MPM BioImpact LLC, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.